Cart
0
Product
Products
(empty)
No products
Free shipping!
Shipping
$0.00
Total
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products
(tax incl.)
Total shipping (tax incl.)
Free shipping!
Total
(tax incl.)
Categories
- Products Overview
- All Products
- Neuropsychochemicals
- SEP-OX Optimized Xtracts
- TLR-OA Optimized Agents
- Neurogenic/Neuroprotection Research
- Addiction Research
- Nootropic Research
- Antidepressant Research
- Anxiolytic/Stress Research
- Analgesia Research
- Vigilance/Focus Research
- Libidogenic Research
- Anti-inflammatory Research
- Cannabinergics
- Glutamatergics
- Opioidergics
- ADD/ADHD Research
- Nicotinergics
- Sleep Promotion Research
- Anti-Obesity Research
- Serotonergics
- Dopaminergics
- Anti-Aging/Longevity Research
- Anti-Cancer Research
- Myotrophic/Anabolic Research
- Anti-Estrogen/Prolactin Research
- Extracts
- Peptides & Antigens
- HairLoss Research
- GABAergics
- Prostaglandin Research
- Revolutionary Research
- Thyroid Research
- Cosmetic Enhancement Research
Nicotinergics
Agents with a dominant or highly significant nicotinergic pathway(s) modulating mechanism of action
Nicotinergics There are 3 products.
Showing 1 - 3 of 3 items
-
-
Alsevetin-OA (TLR-6124) 99%
Alsevetin-OA (TLR-6124) is an optimized agent expressing potent alpha7 NAChR partial agonist activity with moderate efficacy and a high therapeutic index, devoid of tolerance inducing effects. Indications for focus/ADHD, nootropic, anti-addiction, analgesic-sparing research.
$49.70 $71.00 -30%Reduced price!In stock -
NICX-OX Nicotine Cessation Optimized Xtract
NICX-OX Nicotine Cessation Optimized Xtract - Optimized Herbal Extract Formulation to Promote Nicotine Cessation Selectively Modulates Key Nicotinic Receptor Subtypes for Optimized Nicotine Cessation. Research Indications: Addiction Research and Nicotine Cessation
$48.97 $69.95 -30%Reduced price!Buy 3 Get 1 Free Special (Upon Request - Limited Time)
Showing 1 - 3 of 3 items